Suchergebnisse - "An, Jihyun"

PubPharm (144)

11

Ranking of transarterial and targeted therapies for advanced hepatocellular carcinoma in the era of immuno-oncology : A network meta-analysis of randomized sorafenib-controlled trials

enthalten in: Hepatology communications | 2022

von An, J. | Han, S. | Kim, H. | +1

12

Cortisol secretory patterns in deep and moderate neuromuscular blockades in laparoscopic surgery under total intravenous anesthesia : A prospective, single-blinded, randomized controlled trial

enthalten in: Medicine | 2022

von Lee, J. | An, J. | Lee, D. | +4

13

Extrahepatic carcinogenicity of oral nucleos(t)ide analogues in chronic hepatitis B carriers : A 35,000-Korean outcome study

enthalten in: Journal of viral hepatitis | 2022

von Lim, J. | Lee, J. | An, J. | +4

14

Direct-Acting Antivirals for HCV Treatment in Decompensated Liver Cirrhosis Patients : A Systematic Review and Meta-Analysis

enthalten in: Journal of personalized medicine | 2022

von An, J. | Park, D. | Ko, M. | +4

15

Continuous administration of mirabegron has advantages in inhibition of central sensitization compared with short-term treatment cessation in a mouse model of overactive bladder

enthalten in: Neurourology and urodynamics | 2022

von Kwon, J. | Lee, E. | Park, H. | +9

16

Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases

enthalten in: Clinical and molecular hepatology | 2022

von Lee, H. | Chang, Y. | Sung, P. | +9

17

Efficacy and safety of direct-acting antiviral therapy for hepatitis C virus in elderly patients (≥65 years old) : A systematic review and meta-analysis

enthalten in: Journal of viral hepatitis | 2022

von Lee, J. | Ahn, S. | Yim, S. | +5

18

Integrated prognostic and histogenomic justification of stage-directed therapy for single large hepatocellular carcinoma : a Korean nationwide registry study

enthalten in: Gut | 2022

von An, J. | Kim, H. | Oh, B. | +5

CommentOn: Gut. 2020 Oct;69(10):1893-1895. - PMID 31748202

19

PET-Based Radiogenomics Supports mTOR Pathway Targeting for Hepatocellular Carcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von An, J. | Oh, M. | Kim, S. | +9

20

Postresection Period-Specific Hazard of Recurrence as a Framework for Surveillance Strategy in Patients with Hepatocellular Carcinoma : A Multicenter Outcome Study

enthalten in: Liver cancer | 2022

von Kim, H. | An, J. | Kim, J. | +5